Entry - #618822 - CONGENITAL MYOPATHY 9A; CMYP9A - OMIM
# 618822

CONGENITAL MYOPATHY 9A; CMYP9A


Alternative titles; symbols

MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES; MYORIBF


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3q26.33 ?Congenital myopathy 9A with respiratory insufficiency and bone fractures 618822 AR 3 FXR1 600819
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Neck
- Short neck
RESPIRATORY
- Respiratory insufficiency due to muscle weakness
ABDOMEN
Gastrointestinal
- Feeding difficulties
GENITOURINARY
External Genitalia (Male)
- Hypoplastic genitalia
Internal Genitalia (Male)
- Cryptorchidism
SKELETAL
- Joint hyperlaxity
Limbs
- Fractures of the long bones
Hands
- Ulnar deviation of the hands
Feet
- Lateral deviation of the feet
MUSCLE, SOFT TISSUES
- Hypotonia, severe
- Weak cry
- Skeletal muscle shows Z-band streaming
- Minicores disrupt the myofibrillar striation pattern
PRENATAL MANIFESTATIONS
Movement
- Decreased fetal movements
Amniotic Fluid
- Oligohydramnios
MISCELLANEOUS
- Onset in utero
- Death in infancy
- One family has been reported (last curated March 2020)
MOLECULAR BASIS
- Caused by mutation in the FMR1 autosomal homolog 1 gene (FXR1, 600819.0001)
Myopathy, congenital (see also nemaline myopathy (PS161800), myofibrillar myopathy (PS601419), and centronuclear myopathy (PS160150) - PS117000 - 31 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.13 Congenital myopathy 19 AR 3 618578 PAX7 167410
1p36.11 Congenital myopathy 3 with rigid spine AR 3 602771 SELENON 606210
1p31.1 Congenital myopathy 21 with early respiratory failure AR 3 620326 DNAJB4 611327
1q21.3 Congenital myopathy 4A, autosomal dominant AD 3 255310 TPM3 191030
1q21.3 Congenital myopathy 4B, autosomal recessive AR 3 609284 TPM3 191030
1q32.1 Congenital myopathy 18 due to dihydropyridine receptor defect AD, AR 3 620246 CACNA1S 114208
1q42.13 Congenital myopathy 2C, severe infantile, autosomal dominant AD 3 620278 ACTA1 102610
1q42.13 Congenital myopathy 2A, typical, autosomal dominant AD 3 161800 ACTA1 102610
1q42.13 Congenital myopathy 2B, severe infantile, autosomal recessive AR 3 620265 ACTA1 102610
1q43 Congenital myopathy 8 AD 3 618654 ACTN2 102573
2q31.2 Congenital myopathy 5 with cardiomyopathy AR 3 611705 TTN 188840
2q34 Congenital myopathy 14 AR 3 618414 MYL1 160780
3q26.33 Congenital myopathy 9B, proximal, with minicore lesions AR 3 618823 FXR1 600819
3q26.33 ?Congenital myopathy 9A with respiratory insufficiency and bone fractures AR 3 618822 FXR1 600819
5q23.2 Congenital myopathy 10B, mild variant AR 3 620249 MEGF10 612453
5q23.2 Congenital myopathy 10A, severe variant AR 3 614399 MEGF10 612453
9p13.3 Congenital myopathy 23 AD 3 609285 TPM2 190990
10p12.33 Congenital myopathy 11 AR 3 619967 HACD1 610467
11p15.1 Congenital myopathy 17 AR 3 618975 MYOD1 159970
12q12 Congenital myopathy 12 AR 3 612540 CNTN1 600016
12q13.3 Congenital myopathy 13 AR 3 255995 STAC3 615521
12q23.2 Congenital myopathy 16 AD 3 618524 MYBPC1 160794
14q11.2 Congenital myopathy 7B, myosin storage, autosomal recessive AR 3 255160 MYH7 160760
14q11.2 Congenital myopathy 7A, myosin storage, autosomal dominant AD 3 608358 MYH7 160760
15q13.3-q14 Congenital myopathy 20 AR 3 620310 RYR3 180903
17p13.1 Congenital myopathy 6 with ophthalmoplegia AD, AR 3 605637 MYH2 160740
17q23.3 Congenital myopathy 22B, severe fetal AR 3 620369 SCN4A 603967
17q23.3 Congenital myopathy 22A, classic AR 3 620351 SCN4A 603967
19q13.2 Congenital myopathy 1B, autosomal recessive AR 3 255320 RYR1 180901
19q13.2 Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia AD 3 117000 RYR1 180901
20q13.12 Congenital myopathy 15 AD 3 620161 TNNC2 191039

TEXT

A number sign (#) is used with this entry because of evidence that congenital myopathy-9A (CMYP9A) is caused by homozygous mutation in the FXR1 gene (600819) on chromosome 3q28. One such family has been reported.

Biallelic mutation in the FXR1 gene also causes congenital myopathy-9B (CMYP9B; 618823), which is less severe.


Description

Congenital myopathy-9A (CMYP9A) is an autosomal recessive early-onset severe muscular disorder resulting in early death. Affected individuals present at birth with neonatal hypotonia, poor feeding, fractures of the long bones, and respiratory insufficiency. Laboratory investigations are consistent with a defect in early muscle development (summary by Estan et al., 2019).

For a discussion of genetic heterogeneity of congenital myopathy, see CMYP1A (117000).


Clinical Features

Estan et al. (2019) reported 3 sibs, born of consanguineous Egyptian parents (family 1), with a lethal form of congenital myopathy. The proband was a male infant born from a pregnancy characterized by decreased fetal movements and oligohydramnios. At birth, he had severe hypotonia, multiple fractures of the long bones, weak cry, respiratory insufficiency, and episodes of unexplained tachycardia necessitating admission to the neonatal intensive care unit for a month. He had a short neck, skeletal deformities, joint hyperlaxity, ulnar deviation of the hands, laterally deviated feet, and hypoplastic genitalia with cryptorchidism. He died at 5 months of age. A previously born female sib, who was similarly affected, died at 70 days of age. A subsequent pregnancy showed lack of fetal movement, suggesting the same condition; that pregnancy was terminated. Muscle biopsy was not performed, although studies on patient-derived myoblasts and myotubes showed the presence of abnormal cytoplasmic granules.


Inheritance

The transmission pattern of CMYP9A in the family reported by Estan et al. (2019) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a male infant and his affected fetus sib, conceived of consanguineous Egyptian parents (family 1), with CMYP9A, Estan et al. (2019) identified a homozygous 4-bp deletion (c.1764_1767delACAG; 600819.0001) at the 3-prime end of exon 15 of the FXR1 gene. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Primary myoblasts derived from 1 of the patients showed the presence of truncated 82- and 84-kD proteins, consistent with escape from nonsense-mediated mRNA decay (NMD). These abnormal proteins were localized in ring-shaped cytoplasmic granules that contained mRNA. Skeletal muscle from mutant mice carrying the homologous 4-bp deletion showed similar abnormalities (see ANIMAL MODEL).


Animal Model

Estan et al. (2019) found that inactivation of all isoforms of Fxr1 specifically in skeletal muscle myoblasts in mice resulted in neonatal lethality. Generation of the 4-bp deletion (ACAGdel) in exon 15 of the Fxr1 gene, similar to the mutation found in the family with MYORIBF, caused a myopathic phenotype in mice, with decreased body weight, muscle mass, muscle strength, and bone mineral density compared to controls. Skeletal muscle from mutant mice showed reduced fiber size, increased central nuclei, predominance of type 1 fibers, and cores devoid of NADH-TR enzymatic activity. Transmission electron microscopy showed disintegration of Z-bands and sarcomere structure, or disorganized Z-lines and Z-line streaming with abnormal mitochondrial accumulation. RT-PCR analysis showed that the ACAGdel mutation escaped nonsense mediated mRNA decay and resulted in Fxr1 expression at 74.7% of control levels. The mutant truncated protein resulting from the ACAGdel mutation was detected in cytoplasmic granules that contained mRNA, but were not stress granules, suggesting altered mRNA trafficking; this was confirmed by the finding of differentially expressed genes. These findings indicated that skeletal muscle-specific Fxr1 82- and 84-kD proteins are required for maintaining alignment and organization of Z-lines, and that dysregulated translation of specific mRNAs involved in Z-line organization may underlie the myopathic phenotype.


REFERENCES

  1. Estan, M. C., Fernandez-Nunez, E., Zaki, M. S., Esteban, M. I., Donkervoort, S., Hawkins, C., Caparros-Martin, J. A., Saade, D., Hu, Y., Bolduc, V., Chao, K. R.-Y., Nevado, J., and 18 others. Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy. Nature Commun. 10: 797, 2019. Note: Electronic Article. [PubMed: 30770808, images, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 03/22/2020
alopez : 03/10/2023
alopez : 03/09/2023
ckniffin : 03/09/2023
carol : 03/25/2020
ckniffin : 03/23/2020

# 618822

CONGENITAL MYOPATHY 9A; CMYP9A


Alternative titles; symbols

MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES; MYORIBF


DO: 0081343;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
3q26.33 ?Congenital myopathy 9A with respiratory insufficiency and bone fractures 618822 Autosomal recessive 3 FXR1 600819

TEXT

A number sign (#) is used with this entry because of evidence that congenital myopathy-9A (CMYP9A) is caused by homozygous mutation in the FXR1 gene (600819) on chromosome 3q28. One such family has been reported.

Biallelic mutation in the FXR1 gene also causes congenital myopathy-9B (CMYP9B; 618823), which is less severe.


Description

Congenital myopathy-9A (CMYP9A) is an autosomal recessive early-onset severe muscular disorder resulting in early death. Affected individuals present at birth with neonatal hypotonia, poor feeding, fractures of the long bones, and respiratory insufficiency. Laboratory investigations are consistent with a defect in early muscle development (summary by Estan et al., 2019).

For a discussion of genetic heterogeneity of congenital myopathy, see CMYP1A (117000).


Clinical Features

Estan et al. (2019) reported 3 sibs, born of consanguineous Egyptian parents (family 1), with a lethal form of congenital myopathy. The proband was a male infant born from a pregnancy characterized by decreased fetal movements and oligohydramnios. At birth, he had severe hypotonia, multiple fractures of the long bones, weak cry, respiratory insufficiency, and episodes of unexplained tachycardia necessitating admission to the neonatal intensive care unit for a month. He had a short neck, skeletal deformities, joint hyperlaxity, ulnar deviation of the hands, laterally deviated feet, and hypoplastic genitalia with cryptorchidism. He died at 5 months of age. A previously born female sib, who was similarly affected, died at 70 days of age. A subsequent pregnancy showed lack of fetal movement, suggesting the same condition; that pregnancy was terminated. Muscle biopsy was not performed, although studies on patient-derived myoblasts and myotubes showed the presence of abnormal cytoplasmic granules.


Inheritance

The transmission pattern of CMYP9A in the family reported by Estan et al. (2019) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a male infant and his affected fetus sib, conceived of consanguineous Egyptian parents (family 1), with CMYP9A, Estan et al. (2019) identified a homozygous 4-bp deletion (c.1764_1767delACAG; 600819.0001) at the 3-prime end of exon 15 of the FXR1 gene. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Primary myoblasts derived from 1 of the patients showed the presence of truncated 82- and 84-kD proteins, consistent with escape from nonsense-mediated mRNA decay (NMD). These abnormal proteins were localized in ring-shaped cytoplasmic granules that contained mRNA. Skeletal muscle from mutant mice carrying the homologous 4-bp deletion showed similar abnormalities (see ANIMAL MODEL).


Animal Model

Estan et al. (2019) found that inactivation of all isoforms of Fxr1 specifically in skeletal muscle myoblasts in mice resulted in neonatal lethality. Generation of the 4-bp deletion (ACAGdel) in exon 15 of the Fxr1 gene, similar to the mutation found in the family with MYORIBF, caused a myopathic phenotype in mice, with decreased body weight, muscle mass, muscle strength, and bone mineral density compared to controls. Skeletal muscle from mutant mice showed reduced fiber size, increased central nuclei, predominance of type 1 fibers, and cores devoid of NADH-TR enzymatic activity. Transmission electron microscopy showed disintegration of Z-bands and sarcomere structure, or disorganized Z-lines and Z-line streaming with abnormal mitochondrial accumulation. RT-PCR analysis showed that the ACAGdel mutation escaped nonsense mediated mRNA decay and resulted in Fxr1 expression at 74.7% of control levels. The mutant truncated protein resulting from the ACAGdel mutation was detected in cytoplasmic granules that contained mRNA, but were not stress granules, suggesting altered mRNA trafficking; this was confirmed by the finding of differentially expressed genes. These findings indicated that skeletal muscle-specific Fxr1 82- and 84-kD proteins are required for maintaining alignment and organization of Z-lines, and that dysregulated translation of specific mRNAs involved in Z-line organization may underlie the myopathic phenotype.


REFERENCES

  1. Estan, M. C., Fernandez-Nunez, E., Zaki, M. S., Esteban, M. I., Donkervoort, S., Hawkins, C., Caparros-Martin, J. A., Saade, D., Hu, Y., Bolduc, V., Chao, K. R.-Y., Nevado, J., and 18 others. Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy. Nature Commun. 10: 797, 2019. Note: Electronic Article. [PubMed: 30770808] [Full Text: https://doi.org/10.1038/s41467-019-08548-9]


Creation Date:
Cassandra L. Kniffin : 03/22/2020

Edit History:
alopez : 03/10/2023
alopez : 03/09/2023
ckniffin : 03/09/2023
carol : 03/25/2020
ckniffin : 03/23/2020